OGEN Oragenics Inc

Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.

$0.50  -0.02 (-4.00%)
As of 12/03/2021 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/20/2004
Outstanding shares:  116,394,806
Average volume:  2,018,155
Market cap:   $60,280,870
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    684023302
ISIN:        US6840233026
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   2.24
PS ratio:   0.00
Return on equity:   -62.45%
Net income %:   0.00%